The present invention relates to formula (I) compounds: (I) as described herein, pharmaceutical preparation comprising these compounds, purposes of these compounds in the obstacle or disease that treatment MDM2 and/or MDM4 activity mediates, with the method for using these compounds in the obstacle or disease that treatment MDM2 and/or MDM4 activity mediates, and the combination comprising these compounds.本發明涉及式(I)化合物:如本文描述的(I),包含這些化合物的藥物製劑,這些化合物在治療MDM2和/或MDM4活性介導的障礙或疾病中的用途,和在治療MDM2和/或MDM4活性介導的障礙或疾病中使用這些化合物的方法,以及包含這些化合物的組合。